Myocardial Extracellular Volume Is Not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy

被引:0
|
作者
Mirelis, Jesus G. [1 ,2 ,3 ]
Sanchez-Gonzalez, Javier [1 ,4 ]
Zorio, Esther [5 ]
Ripoll-Vera, Tomas [6 ]
Salguero-Bodes, Rafael [7 ]
Filgueiras-Rama, David [1 ,2 ,8 ]
Gonzalez-Lopez, Esther [1 ,2 ,3 ]
Gallego-Delgado, Maria [1 ,2 ]
Fernandez-Jimenez, Rodrigo [1 ,2 ,9 ]
Jesus Soleto, Maria [6 ]
Nunez, Juana [6 ]
Pizarro, Gonzalo [1 ,2 ,10 ]
Sanz, Javier [9 ]
Fuster, Valentin [1 ,9 ]
Garcia-Pavia, Pablo [1 ,2 ]
Ibanez, Borja [1 ,2 ,11 ]
机构
[1] Inst Salud Carlos III, CNIC, Area Fisiopatol Miocardio, Madrid, Spain
[2] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
[3] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[4] Philips Healthcare, Dept Ciencia Clin, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Dept Cardiol, Valencia, Spain
[6] Hosp Son Llatzer & IdISPa, Dept Cardiol, Palma de Mallorca, Spain
[7] Hosp Univ 12 Octubre, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Clin San Carlos, Dept Cardiol, Madrid, Spain
[9] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, Dept Cardiol, New York, NY 10029 USA
[10] Univ Europea Madrid, Complejo Hosp Ruber Juan Bravo, Dept Cardiol, Madrid, Spain
[11] IIS Hosp Fundac Jimenez Diaz, Dept Cardiol, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2017年 / 70卷 / 11期
关键词
Hypertrophic cardiomyopathy; Computed tomography; Extracellular volume; Diffuse fibrosis; CARDIAC MAGNETIC-RESONANCE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; 2011 ACCF/AHA GUIDELINE; SUDDEN-DEATH; TASK-FORCE; PROGNOSTIC VALUE; FIBROSIS; PREVALENCE; PREVENTION; DIAGNOSIS;
D O I
10.1016/j.recesp.2017.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Myocardial interstitial fibrosis, a hallmark of hypertrophic cardiomyopathy (HCM), has been proposed as an arrhythmic substrate. Fibrosis is associated with increased extracellular volume (ECV), which can be quantified by computed tomography (CT). We aimed to analyze the association between CT-determined ECV and malignant ventricular arrhythmias. Methods: A retrospective case-control observational study was conducted in HCM patients with implantable cardioverter-defibrillator, undergoing a CT-protocol with continuous iodine contrast infusion to determine equilibrium ECV. Left ventricular septal and lateral CT-determined ECV was compared between prespecified cases (malignant arrhythmia any time before CT scan) and controls (no prior malignant arrhythmias) and among ECV tertiles. Results: A total of 78 implantable cardioverter-defibrillator HCM patients were included; 24 were women, with a mean age of 52.1 +/- 15.6 years. Mean ECV +/- standard deviation in the septal left ventricular wall and was 29.8% +/- 6.3% in cases (n = 24) vs 31.9% +/- 8.5% in controls (n = 54); P=.282. Mean ECV in the lateral wall was 24.5% +/- 6.8% in cases vs 28.2% +/- 7.4% in controls; P=.043. On comparison of the entire population according to septal ECV tertiles, no significant differences were found in the number of patients receiving appropriate shocks. Conversely, we found a trend (P=.056) for a higher number of patients receiving appropriate shocks in the lateral ECV lowest tertile. Conclusions: Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients. (C) 2017 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:933 / 940
页数:8
相关论文
共 50 条
  • [1] Ventricular arrhythmias complicating hypertrophic cardiomyopathy
    Hutchings, David C.
    Sankaranarayanan, Rajiv
    Venetucci, Luigi
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (09) : 502 - 508
  • [2] Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
    Ariga, Rina
    Tunnicliffe, Elizabeth M.
    Manohar, Sanjay G.
    Mahmod, Masliza
    Raman, Betty
    Piechnik, Stefan K.
    Francis, Jane M.
    Robson, Matthew D.
    Neubauer, Stefan
    Watkins, Hugh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (20) : 2493 - 2502
  • [3] Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy
    Rigopoulos, Angelos G.
    Daci, Silke
    Pfeiffer, Barbara
    Papadopoulou, Konstadia
    Neugebauer, Anna
    Seggewiss, Hubert
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (11) : 953 - 961
  • [4] Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy
    Adduci, Carmen
    Boldini, Francesca
    Palano, Francesca
    Musumeci, Beatrice
    De Lucia, Carmine
    Russo, Domitilla
    Volpe, Massimo
    Autore, Camillo
    Francia, Pietro
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (08) : 2093 - 2098
  • [5] Sudden Cardiac Death and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
    Moore, Benjamin
    Semsarian, Christopher
    Chan, Kim H.
    Sy, Raymond W.
    HEART LUNG AND CIRCULATION, 2019, 28 (01) : 146 - 154
  • [6] Myocardial work is associated with significant left ventricular myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Goncalves, Antonio Valentim
    Rosa, Silvia Aguiar
    Branco, Luisa
    Galrinho, Ana
    Fiarresga, Antonio
    Lopes, Luis Rocha
    Thomas, Boban
    Baquero, Luis
    Carmo, Miguel Mota
    Ferreira, Rui Cruz
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (07) : 2237 - 2244
  • [7] Relation of Late Gadolinium Enhancement and Extracellular Volume Fraction to Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
    Levine, Jonathan
    Collins, Jeremy D.
    Ogele, Emmanuel
    Murtagh, Gillian
    Carr, James C.
    Bonow, Robert O.
    Choudhury, Lubna
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 131 : 104 - 108
  • [8] High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias
    Burczak, Daniel R.
    Newman, D. Brian
    Jaffe, Allan S.
    Ackerman, Michael J.
    Ommen, Steve R.
    Geske, Jeffrey B.
    MAYO CLINIC PROCEEDINGS, 2023, 98 (03) : 410 - 418
  • [9] Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias
    Song, Yanyan
    Bi, Xuanye
    Chen, Liang
    Yang, Kai
    Chen, Xiuyu
    Dong, Zhixiang
    Wang, Jiaxin
    Kong, Xiangyong
    Zhao, Kankan
    Wang, Hongyue
    Duru, Firat
    Lu, Minjie
    Ma, Likun
    Qiao, Shubin
    Zhao, Shihua
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2022, 23 (08) : 1006 - 1015
  • [10] Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy
    Wang, Weijia
    Lian, Zhesi
    Rowin, Ethan J.
    Maron, Barry J.
    Maron, Martin S.
    Link, Mark S.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (03)